{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:30:40Z","timestamp":1785526240446,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["3364"],"award-info":[{"award-number":["3364"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11030-021-10230-6","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:07:16Z","timestamp":1625224036000},"page":"1053-1076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2"],"prefix":"10.1007","volume":"26","author":[{"given":"Rahman","family":"Abdizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Hadizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-562X","authenticated-orcid":false,"given":"Tooba","family":"Abdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"10230_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1787228","volume":"2020","author":"S Chatterjee","year":"2020","unstructured":"Chatterjee S, Maity A, Chowdhury S, Islam MA, Muttinini RK, Sen D (2020) In silico analysis and identification of promising hits against novel coronavirus 3C-like main protease enzyme. J Biomol Struct Dyn 2020:1\u201314. https:\/\/doi.org\/10.1080\/07391102.2020.1787228","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","volume":"163","author":"M Parvez","year":"2020","unstructured":"Parvez M, Alam S, Karim M, Hasan M, Jaman J, Karim Z, Tahsin T, Hasan M, Hosen MJ (2020) Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int J Biol Macromole 163:1787\u20131797. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.098","journal-title":"Int J Biol Macromole"},{"key":"10230_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1758790","author":"I Aanouz","year":"2020","unstructured":"Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-Ldrissi M, Bouachrine M (2020) Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1758790","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"10230_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/v12020194","volume":"12","author":"DA Schwartz","year":"2020","unstructured":"Schwartz DA, Graham AL (2020) Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 12(2):194. https:\/\/doi.org\/10.3390\/v12020194","journal-title":"Viruses"},{"issue":"1","key":"10230_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccm.2016.11.007","volume":"38","author":"DS Hui","year":"2017","unstructured":"Hui DS (2017) Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome). Clin Chest Med 38(1):71\u201386. https:\/\/doi.org\/10.1016\/j.ccm.2016.11.007","journal-title":"Clin Chest Med"},{"issue":"10","key":"10230_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","volume":"13","author":"CB Reusken","year":"2013","unstructured":"Reusken CB, Haagmans BL, M\u00fcller MA, Gutierrez C, Godeke G-J, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM (2013) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13(10):859\u2013866. https:\/\/doi.org\/10.1016\/S1473-3099(13)70164-6","journal-title":"Lancet Infect Dis"},{"key":"10230_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1832580","author":"A Kallingal","year":"2020","unstructured":"Kallingal A, Thachan Kundil V, Ayyolath A, Karlapudi AP, Muringayil Joseph T (2020) Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1832580","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2020.107717","author":"V Kodchakorn","year":"2020","unstructured":"Kodchakorn V, Poovorawan Y, Suwannakarn K, Kongtawelert P (2020) Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2. J Mol Graph Model. https:\/\/doi.org\/10.1016\/j.jmgm.2020.107717","journal-title":"J Mol Graph Model"},{"issue":"10225","key":"10230_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","volume":"395","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Leung GM (2020) Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet 395(10225):689\u2013697. https:\/\/doi.org\/10.1016\/S0140-6736(20)30260-9","journal-title":"The Lancet"},{"key":"10230_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.06.004","author":"AH Al-Rohaimi","year":"2020","unstructured":"Al-Rohaimi AH, Al Otaibi F (2020) Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic. Genes Dis. https:\/\/doi.org\/10.1016\/j.gendis.2020.06.004","journal-title":"Genes Dis"},{"key":"10230_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.03.019","author":"H Harapan","year":"2020","unstructured":"Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Megawati D, Hayati Z, Wagner AL, Mudatsir M (2020) Coronavirus disease 2019 (COVID-19): a literature review. J Infect Pub Health. https:\/\/doi.org\/10.1016\/j.jiph.2020.03.019","journal-title":"J Infect Pub Health"},{"issue":"8","key":"10230_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"10230_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13089","author":"JR Lechien","year":"2020","unstructured":"Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S (2020) Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. https:\/\/doi.org\/10.1111\/joim.13089","journal-title":"J Intern Med"},{"issue":"10224","key":"10230_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 395(10224):565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"The Lancet"},{"key":"10230_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761883","author":"R Islam","year":"2020","unstructured":"Islam R, Parves MR, Paul AS, Uddin N, Rahman MS, Mamun AA, Hossain MN, Ali MA, Halim MA (2020) A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1761883","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1779128","author":"A Khan","year":"2020","unstructured":"Khan A, Ali SS, Khan MT, Saleem S, Ali A, Suleman M, Babar Z, Shafiq A, Khan M, Wei D-Q (2020) Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro). J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1779128","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C (2020) Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"10230_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129489","author":"R Ghosh","year":"2020","unstructured":"Ghosh R, Chakraborty A, Biswas A, Chowdhuri S (2020) Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129489","journal-title":"J Mol Struct"},{"issue":"1","key":"10230_CR19","doi-asserted-by":"publisher","first-page":"e03217","DOI":"10.1016\/j.heliyon.2020.e03217","volume":"6","author":"S Mishra","year":"2020","unstructured":"Mishra S, Pandey A, Manvati S (2020) Coumarin: an emerging antiviral agent. Heliyon 6(1):e03217. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03217","journal-title":"Heliyon"},{"key":"10230_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","volume":"123","author":"MZ Hassan","year":"2016","unstructured":"Hassan MZ, Osman H, Ali MA, Ahsan MJ (2016) Therapeutic potential of coumarins as antiviral agents. Eur J Med Chem 123:236\u2013255. https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.056","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10230_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1875-5364(18)30003-7","volume":"15","author":"L Huang","year":"2017","unstructured":"Huang L, Zhe-Ling F, Yi-Tao W, Li-Gen L (2017) Anticancer carbazole alkaloids and coumarins from Clausena plants: a review. Chin J Nat Med 15(12):881\u2013888. https:\/\/doi.org\/10.1016\/S1875-5364(18)30003-7","journal-title":"Chin J Nat Med"},{"key":"10230_CR22","doi-asserted-by":"publisher","first-page":"112514","DOI":"10.1016\/j.ejmech.2020.112514","volume":"203","author":"GA Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves GA, Spillere AR, Das Neves GM, Kagami LP, Von Poser GL, Canto RFS, Eifler-Lima VL (2020) Natural and synthetic coumarins as antileishmanial agents: a review. Eur. J. Med. Chem 203:112514. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112514","journal-title":"Eur. J. Med. Chem"},{"issue":"3","key":"10230_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.phymed.2013.09.001","volume":"21","author":"A Witaicenis","year":"2014","unstructured":"Witaicenis A, Seito LN, da Silveira Chagas A, de Almeida Junior LD, Luchini AC, Rodrigues-Orsi P, Cestari SH, Di Stasi LC (2014) Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine 21(3):240\u2013246. https:\/\/doi.org\/10.1016\/j.phymed.2013.09.001","journal-title":"Phytomedicine"},{"issue":"6","key":"10230_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0031-9422(99)00554-3","volume":"53","author":"P Zhou","year":"2000","unstructured":"Zhou P, Takaishi Y, Duan H, Chen B, Honda G, Itoh M, Takeda Y, Kodzhimatov OK, Lee K-H (2000) Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. Phytochemistry 53(6):689\u2013697. https:\/\/doi.org\/10.1016\/S0031-9422(99)00554-3","journal-title":"Phytochemistry"},{"key":"10230_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/963248","author":"KN Venugopala","year":"2013","unstructured":"Venugopala KN, Rashmi V, Odhav B (2013) Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/963248","journal-title":"Biomed Res Int"},{"issue":"7","key":"10230_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1248\/cpb.49.877","volume":"49","author":"Y Shikishima","year":"2001","unstructured":"Shikishima Y, Takaishi Y, Honda G, Ito M, Takeda Y, Kodzhimatov OK, Ashurmetov O, LEE KH (2001) Chemical constituents of Prangos tschimganica; structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity. Chem. Pharm. Bull. 49(7):877\u2013880. https:\/\/doi.org\/10.1248\/cpb.49.877","journal-title":"Chem. Pharm. Bull."},{"issue":"2\u20133","key":"10230_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.antiviral.2005.02.006","volume":"66","author":"N M\u00e1rquez","year":"2005","unstructured":"M\u00e1rquez N, Sancho R, Bedoya LM, Alcam\u00ed J, L\u00f3pez-P\u00e9rez JL, San Feliciano A, Fiebich BL, Mu\u00f1oz E (2005) a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-\u03baB pathway. Antivir. Res. 66(2\u20133):137\u2013145. https:\/\/doi.org\/10.1016\/j.antiviral.2005.02.006","journal-title":"Antivir. Res."},{"issue":"1","key":"10230_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1128\/AAC.01259-13","volume":"58","author":"B Xu","year":"2014","unstructured":"Xu B, Wang L, Gonz\u00e1lez-Molleda L, Wang Y, Xu J, Yuan Y (2014) Antiviral activity of (+)-rutamarin against Kaposi\u2019s sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. Antimicrob Agents Chemother 58(1):563\u2013573. https:\/\/doi.org\/10.1128\/AAC.01259-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10230_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/1348-0421.12127","volume":"58","author":"M Adianti","year":"2014","unstructured":"Adianti M, Aoki C, Komoto M, Deng L, Shoji I, Wahyuni TS, Lusida MI, Fuchino H, Kawahara N, Hotta H (2014) Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species. Microbiol Immunol 58(3):180\u2013187. https:\/\/doi.org\/10.1111\/1348-0421.12127","journal-title":"Microbiol Immunol"},{"issue":"2","key":"10230_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1076\/phbi.41.2.107.14240","volume":"41","author":"RW Perez","year":"2003","unstructured":"Perez RW (2003) Antiviral activity of compounds isolated from plants. Pharm Biol 41(2):107\u2013157. https:\/\/doi.org\/10.1076\/phbi.41.2.107.14240","journal-title":"Pharm Biol"},{"key":"10230_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.12688\/f1000research.22457.2","volume":"9","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yiu CPB, Wong K-Y (2020) Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: Virtual screening reveals velpatasvir, and other drug repurposing candidates. F1000Res. 9:129. https:\/\/doi.org\/10.12688\/f1000research.22457.2","journal-title":"F1000Res."},{"key":"10230_CR32","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.ejps.2021.105744","volume":"160","author":"MA Said","year":"2021","unstructured":"Said MA, Albohy A, m.A. abdelrahman, H.S. Ibrahim, (2021) Important of glutamine 189 flexibility in SARS-CoV-2 main protease: lesson learned from in silico virtual screening of ChEMBL database and molecular dynamicd. Eur. J. Pharm. Sci. 160:105744. https:\/\/doi.org\/10.1016\/j.ejps.2021.105744","journal-title":"Eur. J. Pharm. Sci."},{"key":"10230_CR33","doi-asserted-by":"publisher","first-page":"16752","DOI":"10.1039\/D0NJ03611K","volume":"44","author":"AA Zaki","year":"2020","unstructured":"Zaki AA, Al-Karmalawy AA, El-Amierc YA, Ashour A (2020) Molecular docking reveals the potential of Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease. New J Chem 44:16752\u201316758. https:\/\/doi.org\/10.1039\/D0NJ03611K","journal-title":"New J Chem"},{"key":"10230_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1872419","author":"S Shah","year":"2020","unstructured":"Shah S, Chaple D, Arora S, Yende S, Mehta C, Nayak U (2020) Prospecting for cressa cretica to treat COVID-19 via in silico molecular docking models of the SARSCoV-2. J Biomol Struct Dy. https:\/\/doi.org\/10.1080\/07391102.2021.1872419","journal-title":"J Biomol Struct Dy"},{"issue":"1\u20133","key":"10230_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10230_CR36","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"issue":"21","key":"10230_CR37","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43(21):3867\u20133877. https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"issue":"12","key":"10230_CR38","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44(12):1841\u20131846. https:\/\/doi.org\/10.1021\/jm015507e","journal-title":"J Med Chem"},{"key":"10230_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1760136","author":"SK Enmozhi","year":"2020","unstructured":"Enmozhi SK, Raja K, Sebastine I, Joseph J (2020) Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1760136","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1779129","author":"D Prasanth","year":"2020","unstructured":"Prasanth D, Murahari M, Chandramohan V, Panda SP, Atmakuri LR, Guntupalli C (2020) In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1779129","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"10230_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2020.104046","author":"MAA Ibrahim","year":"2020","unstructured":"Ibrahim MAA, Abdelrahman AHM, Hussien T, Badr EAA, Mohamed TA, El-Seedi HR, Pare PW, Efferth T, Hegazy MEF (2020) In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitor. Comput Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2020.104046","journal-title":"Comput Biol Med"},{"key":"10230_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772108","author":"V Kumar","year":"2020","unstructured":"Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D (2020) Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1772108","journal-title":"J Biomol Struct Dyn"},{"issue":"8","key":"10230_CR44","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Sch\u00fcttelkopf","year":"2004","unstructured":"Sch\u00fcttelkopf AW, Van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Cryst D: Biol Crystal 60(8):1355\u20131363. https:\/\/doi.org\/10.1107\/S0907444904011679","journal-title":"Acta Cryst D: Biol Crystal"},{"key":"10230_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1757510","author":"S Pant","year":"2020","unstructured":"Pant S, Singh M, Ravichandiran V, Murty U, Srivastava HK (2020) Peptide-like and small-molecule inhibitors against Covid-19. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1757510","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1758789","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA, Azzam EB (2020) Novel Guanosine Derivatives against MERS CoV polymerase: an in silico perspective. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1758789","journal-title":"J Biomol Struct Dyn"},{"key":"10230_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1763202","author":"D Umesh","year":"2020","unstructured":"Umesh D, Kundu C, Selvaraj SK, Singh V.K. D. (2020) Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1763202","journal-title":"J Biomol Struct Dyn"},{"issue":"9","key":"10230_CR48","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/acs.jcim.7b00347","volume":"57","author":"M Aldeghi","year":"2017","unstructured":"Aldeghi M, Bodkin MJ, Knapp S, Biggin PC (2017) Statistical analysis on the performance of Molecular Mechanics Poisson-Boltzmann Surface Area versus absolute binding free energy calculations: bromodomains as a case study. J Chem Inf Model 57(9):2203\u20132221. https:\/\/doi.org\/10.1021\/acs.jcim.7b00347","journal-title":"J Chem Inf Model"},{"issue":"5","key":"10230_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"10230_CR50","doi-asserted-by":"publisher","unstructured":"R. Kumari, R. Kumar, O.S.D.D. Consortium, A. Lynn, g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model. 54(7) (2014) 1951-1962. https:\/\/doi.org\/https:\/\/doi.org\/10.1021\/ci500020m","DOI":"10.1021\/ci500020m"},{"issue":"23","key":"10230_CR51","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1073\/pnas.1835675100","volume":"100","author":"H Yang","year":"2003","unstructured":"Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z (2003) The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci 100(23):13190\u201313195. https:\/\/doi.org\/10.1073\/pnas.1835675100","journal-title":"Proc Natl Acad Sci"},{"key":"10230_CR52","volume-title":"Natural products as antiviral agents studies in natural products chemistry","author":"KA El Sayed","year":"2000","unstructured":"El Sayed KA (2000) Natural products as antiviral agents studies in natural products chemistry. Elsevier, Amsterdam"},{"issue":"11","key":"10230_CR53","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1055\/s-2003-45154","volume":"69","author":"V Reutrakul","year":"2003","unstructured":"Reutrakul V, Leewanich P, Tuchinda P, Pohmakotr M, Jaipetch T, Sophasan S, Santisuk T (2003) Cytotoxic coumarins from Mammea harmandii. Planta Med 69(11):1048\u20131051. https:\/\/doi.org\/10.1055\/s-2003-45154","journal-title":"Planta Med"},{"key":"10230_CR54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1248\/cpb.49.877","volume":"49","author":"Y Shikishima","year":"2001","unstructured":"Shikishima Y, Takaishi Y, Honda G, Ito M, Takfda Y, Kodzhimotov O, Ashurmetov O, Lee K (2001) Chemical constituents of prangos tschimganica; structure elucidation and absolute configuration of coumarin and furano coumarin derivatives with anti-HIV activity. Chem Pharm Bull 49:877\u2013880. https:\/\/doi.org\/10.1248\/cpb.49.877","journal-title":"Chem Pharm Bull"},{"key":"10230_CR55","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10230_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40495-019-00181-w","volume":"5","author":"MY Al-Nour","year":"2019","unstructured":"Al-Nour MY, Ibrahim MM, Elsaman T (2019) Ellagic acid, kaempferol, and quercetin from acacia nilotica: promising combined drug with multiple mechanisms of action. Curr Pharmacol Rep 5:255\u2013280. https:\/\/doi.org\/10.1007\/s40495-019-00181-w","journal-title":"Curr Pharmacol Rep"},{"issue":"4","key":"10230_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejbas.2018.10.002","volume":"5","author":"P Chinnasamy","year":"2018","unstructured":"Chinnasamy P, Arumugam R (2018) In silico prediction of anticarcinogenic bioactivities of traditional anti-inflammatory plants used by tribal healers in Sathyamangalam wildlife Sanctuary, India. Egypt J Basic Appl Sci 5(4):265\u2013279. https:\/\/doi.org\/10.1016\/j.ejbas.2018.10.002","journal-title":"Egypt J Basic Appl Sci"},{"key":"10230_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00044-017-2036-1","volume":"27","author":"P Sethi","year":"2018","unstructured":"Sethi P, Bansal Y, Bansal G (2018) Synthesis and PASS-assisted evaluation of coumarin-benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents. Med Chem Res 27:61\u201371. https:\/\/doi.org\/10.1007\/s00044-017-2036-1","journal-title":"Med Chem Res"},{"key":"10230_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1800514","author":"NA Al-SharI","year":"2020","unstructured":"Al-SharI NA (2020) Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1800514","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"10230_CR60","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","volume":"60","author":"J Wang","year":"2020","unstructured":"Wang J (2020) Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. J Chem Inf Model 60(6):3277\u20133286. https:\/\/doi.org\/10.1021\/acs.jcim.0c00179","journal-title":"J Chem Inf Model"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10230-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T18:15:48Z","timestamp":1651601748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10230"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10230-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any study with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}